| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-13 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-12 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-11 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-11 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
1e-10 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-10 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-10 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-10 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-10 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-10 |